Probucol for Symptomatic Intracranial and Extracranial Artery Stenosis
Status:
RECRUITING
Trial end date:
2026-10-31
Target enrollment:
Participant gender:
Summary
This study is a multicenter, double-blind, placebo-controlled, randomized clinical trial that aims to evaluate the efficacy of probucol on the reduction of the risk of recurrent stroke in patients with symptomatic intracranial or extracranial arterial stenosis.
Phase:
PHASE3
Details
Lead Sponsor:
First Affiliated Hospital of Wannan Medical College